Identification of patients for a delayed extubation strategy versus elective tracheostomy for postoperative airway management in major oral cancer surgery: A prospective observational study in seven hundred and twenty patients

Objectives: Tracheostomy (TT) and delayed extubation (DE) are two approaches to postoperative airway management in patients after major oral cancer surgery. We planned a study to determine the safety of overnight intubation followed by extubation the next morning (DE) compared to elective TT and to...

Full description

Bibliographic Details
Main Authors: D'Cruz, A.K (Author), Dhar, H. (Author), Divatia, J.V (Author), Gupta, S. (Author), Myatra, S.N (Author), Rajanala, V. (Author), Sharma, S. (Author)
Format: Article
Language:English
Published: Elsevier Ltd 2021
Subjects:
Online Access:View Fulltext in Publisher
LEADER 04775nam a2201069Ia 4500
001 10.1016-j.oraloncology.2021.105502
008 220427s2021 CNT 000 0 und d
020 |a 13688375 (ISSN) 
245 1 0 |a Identification of patients for a delayed extubation strategy versus elective tracheostomy for postoperative airway management in major oral cancer surgery: A prospective observational study in seven hundred and twenty patients 
260 0 |b Elsevier Ltd  |c 2021 
856 |z View Fulltext in Publisher  |u https://doi.org/10.1016/j.oraloncology.2021.105502 
520 3 |a Objectives: Tracheostomy (TT) and delayed extubation (DE) are two approaches to postoperative airway management in patients after major oral cancer surgery. We planned a study to determine the safety of overnight intubation followed by extubation the next morning (DE) compared to elective TT and to identify factors that were associated with a safe DE (maintenance of a patent airway). Material and methods: We conducted a prospective observational study in a tertiary referral cancer care center. We included adult patients undergoing elective major oral cancer surgery under general anesthesia with tracheal intubation. The decision regarding postoperative airway management using either TT or DE was made according to the usual practice at our center. Results: We screened a total of 4477 patients, 720 patients were included. DE was performed in 417 patients (58.4%) and TT in 303 patients (42.4%). On multivariable analysis, T1-T2 tumor stage, absence of extensive resection, primary closure or reconstruction using fasciocutaneous flap, absence of preoperative radiation, no neck dissection or unilateral neck dissection and shorter duration of anesthesia were independent predictors for a safe DE. Overall complications (4.3% versus 22.5%, p = 0.00) and airway complications (1.7% versus 8.7%, p = 0.00) were lower in the DE compared to the TT group respectively. DE was associated with a shorter hospital stay (7.2 ± 3.7 versus 11.5 ± 7.2 days, p = 0.00), time to oral intake and speech compared to TT. Conclusions: A DE strategy after major oral cancer surgery is a safe alternative to TT in a select group of patients. © 2021 
650 0 4 |a adult 
650 0 4 |a Airway extubation 
650 0 4 |a Airway Extubation 
650 0 4 |a Airway management 
650 0 4 |a Airway Management 
650 0 4 |a analgesic agent 
650 0 4 |a artery thrombosis 
650 0 4 |a Article 
650 0 4 |a bronchospasm 
650 0 4 |a cancer center 
650 0 4 |a cancer staging 
650 0 4 |a cancer surgery 
650 0 4 |a clinical practice 
650 0 4 |a cohort analysis 
650 0 4 |a Complications of airway management 
650 0 4 |a Delayed extubation 
650 0 4 |a elective surgery 
650 0 4 |a Elective tracheostomy 
650 0 4 |a endotracheal intubation 
650 0 4 |a extubation 
650 0 4 |a fasciocutaneous flap 
650 0 4 |a female 
650 0 4 |a fentanyl 
650 0 4 |a fistula 
650 0 4 |a flap congestion 
650 0 4 |a flap dehiscence 
650 0 4 |a fluid intake 
650 0 4 |a general anesthesia 
650 0 4 |a graft necrosis 
650 0 4 |a heart muscle ischemia 
650 0 4 |a human 
650 0 4 |a Humans 
650 0 4 |a hyperglycemia 
650 0 4 |a hyponatremia 
650 0 4 |a isoflurane 
650 0 4 |a length of stay 
650 0 4 |a lidocaine 
650 0 4 |a major clinical study 
650 0 4 |a male 
650 0 4 |a mouth cancer 
650 0 4 |a Mouth neoplasms 
650 0 4 |a Mouth Neoplasms 
650 0 4 |a mouth tumor 
650 0 4 |a neck bleeding 
650 0 4 |a neck dissection 
650 0 4 |a neck hematoma 
650 0 4 |a neostigmine 
650 0 4 |a neuromuscular blocking agent 
650 0 4 |a observational study 
650 0 4 |a oxygen therapy 
650 0 4 |a patient assessment 
650 0 4 |a patient safety 
650 0 4 |a peroperative care 
650 0 4 |a Post-operative airway in oral cancer 
650 0 4 |a postoperative care 
650 0 4 |a postoperative complication 
650 0 4 |a postoperative infection 
650 0 4 |a preoperative radiotherapy 
650 0 4 |a procedures 
650 0 4 |a propofol 
650 0 4 |a Prospective Studies 
650 0 4 |a prospective study 
650 0 4 |a reconstructive surgery 
650 0 4 |a respiration control 
650 0 4 |a respiration control 
650 0 4 |a risk factor 
650 0 4 |a seroma 
650 0 4 |a sevoflurane 
650 0 4 |a speech 
650 0 4 |a tertiary care center 
650 0 4 |a tracheostomy 
650 0 4 |a Tracheostomy 
700 1 |a D'Cruz, A.K.  |e author 
700 1 |a Dhar, H.  |e author 
700 1 |a Divatia, J.V.  |e author 
700 1 |a Gupta, S.  |e author 
700 1 |a Myatra, S.N.  |e author 
700 1 |a Rajanala, V.  |e author 
700 1 |a Sharma, S.  |e author 
773 |t Oral Oncology